09:09 uur 19-05-2020

Met Veeva kunnen CRO’s sneller studies bouwen met Vault EDC

5 van de top 7 CRO’s sluiten zich aan bij het Vault CDMS CRO-partnerprogramma om de implementatie van hoogwaardige klinische onderzoeken te versnellen

BARCELONA, Spanje– (BUSINESS WIRE) – Veeva R&D Summit, Europa, 2020Veeva Systems (NYSE: VEEV) heeft vandaag een nieuw partnerprogramma aangekondigd om CRO’s te helpen sneller studies op te bouwen met Veeva Vault EDC. Als onderdeel van het CRO-partnerprogramma worden CRO’s getraind en ontvangen ze best practices voor het rechtstreeks configureren van casebooks vanuit een protocol met Studio, een nieuwe ontwerpinnovatie in Vault EDC om de bouwtijden voor studies te verminderen. Tien wereldwijde CRO’s, waaronder 5 van de top 7 grootste CRO’s, maken al deel uit van het programma om studies voor sponsors te configureren.

Vault EDC maakt een agile ontwerpbenadering mogelijk voor het configureren van casebooks door het voor klinische programmeurs gemakkelijker te maken om formulieren, componenten en regels opnieuw te gebruiken tijdens het bouwen van de database. CRO’s kunnen tijdens het bouwproces effectiever samenwerken met sponsors en in realtime wijzigingen aanbrengen in het casusrapport. Dit vermindert de tijd en moeite van klinische programmeurs aanzienlijk om een ​​onderzoeksdatabase op te bouwen, zodat de gegevensverzameling eerder kan beginnen.

Veeva Enables CROs to Build Studies Faster with Vault EDC

5 of the top 7 CROs join Vault CDMS CRO partner program to speed the deployment of high-quality clinical trials

BARCELONA, Spain–(BUSINESS WIRE)– 2020 Veeva R&D Summit, Europe — Veeva Systems (NYSE:VEEV) today announced a new partner program to help CROs build studies faster using Veeva Vault EDC. As part of the CRO partner program, CROs are trained and receive best practices configuring casebooks directly from a protocol with Studio, a new design innovation in Vault EDC to reduce study build times. Ten global CROs, including 5 of the top 7 largest CROs, are already part of the program to configure studies for sponsors.

Vault EDC enables an agile design approach for configuring casebooks by making it easier for clinical programmers to reuse forms, components, and rules during the database build. CROs can collaborate more effectively with sponsors during the build process and make changes to the case report form in real-time. This significantly reduces the time and effort of clinical programmers to build a study database so that data collection can start sooner.

With the CRO partner program, Veeva is enabling a growing network of CROs trained to configure casebooks in Vault EDC. CROs receive 2-4 weeks of training, best practices in agile design, and mentoring during their first casebook build. CROs are fully trained to build complex studies and make mid-study changes quickly with Vault EDC.

“We are making it easier for CROs to build quality studies and get them up and running faster for sponsors,” said Richard Young, vice president of strategy for Veeva Vault CDMS. “Sponsors can have the confidence that CROs are ready to configure the most complex studies and deploy study amendments faster than ever before with Veeva Vault EDC.”

In other news, Veeva today announced MyVeeva, a multichannel patient portal for virtual visits and patient-centric trials, and Veeva Vault Site Connect, an application that connects sponsors and clinical research sites during studies. Both are part of the Veeva Clinical Network, a set of solutions that enables sponsors, sites, and patients to share and view information and accelerate clinical research.

Learn more about Vault EDC and Vault CDMS at the online Veeva R&D Summit, 19-20 and 26 May, 2020. CROs interested in hearing more about the partner program can contact info@veeva.com.

Additional Information

Connect with Veeva on LinkedIn: linkedin.com/company/veeva-systems
Follow @veeva_eu on Twitter: twitter.com/veeva_eu
Like Veeva on Facebook: facebook.com/veevasystems

About Veeva Systems

Veeva Systems Inc. is the leader in cloud-based software for the global life sciences industry. Committed to innovation, product excellence, and customer success, Veeva serves more than 850 customers, ranging from the world’s largest pharmaceutical companies to emerging biotechs. Veeva is headquartered in the San Francisco Bay Area, with offices throughout North America, Europe, Asia, and Latin America. For more information, visit veeva.com/eu.

Forward-looking Statements

This release contains forward-looking statements, including the market demand for and acceptance of Veeva’s products and services, the results from use of Veeva’s products and services, and general business conditions, particularly in the life sciences industry. Any forward-looking statements contained in this press release are based upon Veeva’s historical performance and its current plans, estimates, and expectations, and are not a representation that such plans, estimates, or expectations will be achieved. These forward-looking statements represent Veeva’s expectations as of the date of this press announcement. Subsequent events may cause these expectations to change, and Veeva disclaims any obligation to update the forward-looking statements in the future. These forward-looking statements are subject to known and unknown risks and uncertainties that may cause actual results to differ materially. Additional risks and uncertainties that could affect Veeva’s financial results are included under the captions, “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” in the company’s filing on Form 10-K for the period ended January 31, 2020. This is available on the company’s website at veeva.com under the Investors section and on the SEC’s website at sec.gov. Further information on potential risks that could affect actual results will be included in other filings Veeva makes with the SEC from time to time.

® 2020 Veeva Systems Inc. All rights reserved. Veeva and the Veeva logo are trademarks of Veeva Systems Inc.

Veeva Systems Inc. owns other registered and unregistered trademarks.

Contacts

Roger Villareal

Veeva Systems

925-264-8885

roger.villareal@veeva.com

Kiran May

Veeva Systems

+44-796-643-2912

kiran.may@veeva.com

Check out our twitter: @NewsNovumpr